Global Opioid Use Disorder Market Size, Status and Forecast 2024-2031

Report ID: 949528 | Published Date: Sep 2024 | No. of Page: 98 | Base Year: 2023 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Opioid Use Disorder Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Buprenorphine
        1.2.3 Methadone
        1.2.4 Naltrexone
    1.3 Market by Application
        1.3.1 Global Opioid Use Disorder Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Moderate Pain Treatment
        1.3.3 Severe Pain Treatment
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Opioid Use Disorder Market Perspective (2016-2027)
    2.2 Opioid Use Disorder Growth Trends by Regions
        2.2.1 Opioid Use Disorder Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Opioid Use Disorder Historic Market Share by Regions (2016-2021)
        2.2.3 Opioid Use Disorder Forecasted Market Size by Regions (2022-2027)
    2.3 Opioid Use Disorder Industry Dynamic
        2.3.1 Opioid Use Disorder Market Trends
        2.3.2 Opioid Use Disorder Market Drivers
        2.3.3 Opioid Use Disorder Market Challenges
        2.3.4 Opioid Use Disorder Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Opioid Use Disorder Players by Revenue
        3.1.1 Global Top Opioid Use Disorder Players by Revenue (2016-2021)
        3.1.2 Global Opioid Use Disorder Revenue Market Share by Players (2016-2021)
    3.2 Global Opioid Use Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Opioid Use Disorder Revenue
    3.4 Global Opioid Use Disorder Market Concentration Ratio
        3.4.1 Global Opioid Use Disorder Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Opioid Use Disorder Revenue in 2020
    3.5 Opioid Use Disorder Key Players Head office and Area Served
    3.6 Key Players Opioid Use Disorder Product Solution and Service
    3.7 Date of Enter into Opioid Use Disorder Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Opioid Use Disorder Breakdown Data by Type
    4.1 Global Opioid Use Disorder Historic Market Size by Type (2016-2021)
    4.2 Global Opioid Use Disorder Forecasted Market Size by Type (2022-2027)

5 Opioid Use Disorder Breakdown Data by Application
    5.1 Global Opioid Use Disorder Historic Market Size by Application (2016-2021)
    5.2 Global Opioid Use Disorder Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Opioid Use Disorder Market Size (2016-2027)
    6.2 North America Opioid Use Disorder Market Size by Type
        6.2.1 North America Opioid Use Disorder Market Size by Type (2016-2021)
        6.2.2 North America Opioid Use Disorder Market Size by Type (2022-2027)
        6.2.3 North America Opioid Use Disorder Market Size by Type (2016-2027)
    6.3 North America Opioid Use Disorder Market Size by Application
        6.3.1 North America Opioid Use Disorder Market Size by Application (2016-2021)
        6.3.2 North America Opioid Use Disorder Market Size by Application (2022-2027)
        6.3.3 North America Opioid Use Disorder Market Size by Application (2016-2027)
    6.4 North America Opioid Use Disorder Market Size by Country
        6.4.1 North America Opioid Use Disorder Market Size by Country (2016-2021)
        6.4.2 North America Opioid Use Disorder Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Opioid Use Disorder Market Size (2016-2027)
    7.2 Europe Opioid Use Disorder Market Size by Type
        7.2.1 Europe Opioid Use Disorder Market Size by Type (2016-2021)
        7.2.2 Europe Opioid Use Disorder Market Size by Type (2022-2027)
        7.2.3 Europe Opioid Use Disorder Market Size by Type (2016-2027)
    7.3 Europe Opioid Use Disorder Market Size by Application
        7.3.1 Europe Opioid Use Disorder Market Size by Application (2016-2021)
        7.3.2 Europe Opioid Use Disorder Market Size by Application (2022-2027)
        7.3.3 Europe Opioid Use Disorder Market Size by Application (2016-2027)
    7.4 Europe Opioid Use Disorder Market Size by Country
        7.4.1 Europe Opioid Use Disorder Market Size by Country (2016-2021)
        7.4.2 Europe Opioid Use Disorder Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Opioid Use Disorder Market Size (2016-2027)
    8.2 Asia-Pacific Opioid Use Disorder Market Size by Type
        8.2.1 Asia-Pacific Opioid Use Disorder Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Opioid Use Disorder Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Opioid Use Disorder Market Size by Type (2016-2027)
    8.3 Asia-Pacific Opioid Use Disorder Market Size by Application
        8.3.1 Asia-Pacific Opioid Use Disorder Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Opioid Use Disorder Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Opioid Use Disorder Market Size by Application (2016-2027)
    8.4 Asia-Pacific Opioid Use Disorder Market Size by Region
        8.4.1 Asia-Pacific Opioid Use Disorder Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Opioid Use Disorder Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Opioid Use Disorder Market Size (2016-2027)
    9.2 Latin America Opioid Use Disorder Market Size by Type
        9.2.1 Latin America Opioid Use Disorder Market Size by Type (2016-2021)
        9.2.2 Latin America Opioid Use Disorder Market Size by Type (2022-2027)
        9.2.3 Latin America Opioid Use Disorder Market Size by Type (2016-2027)
    9.3 Latin America Opioid Use Disorder Market Size by Application
        9.3.1 Latin America Opioid Use Disorder Market Size by Application (2016-2021)
        9.3.2 Latin America Opioid Use Disorder Market Size by Application (2022-2027)
        9.3.3 Latin America Opioid Use Disorder Market Size by Application (2016-2027)
    9.4 Latin America Opioid Use Disorder Market Size by Country
        9.4.1 Latin America Opioid Use Disorder Market Size by Country (2016-2021)
        9.4.2 Latin America Opioid Use Disorder Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Opioid Use Disorder Market Size (2016-2027)
    10.2 Middle East & Africa Opioid Use Disorder Market Size by Type
        10.2.1 Middle East & Africa Opioid Use Disorder Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Opioid Use Disorder Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Opioid Use Disorder Market Size by Type (2016-2027)
    10.3 Middle East & Africa Opioid Use Disorder Market Size by Application
        10.3.1 Middle East & Africa Opioid Use Disorder Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Opioid Use Disorder Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Opioid Use Disorder Market Size by Application (2016-2027)
    10.4 Middle East & Africa Opioid Use Disorder Market Size by Country
        10.4.1 Middle East & Africa Opioid Use Disorder Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Opioid Use Disorder Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Indivior
        11.1.1 Indivior Company Details
        11.1.2 Indivior Business Overview
        11.1.3 Indivior Opioid Use Disorder Introduction
        11.1.4 Indivior Revenue in Opioid Use Disorder Business (2016-2021)
        11.1.5 Indivior Recent Development
    11.2 Alkermes
        11.2.1 Alkermes Company Details
        11.2.2 Alkermes Business Overview
        11.2.3 Alkermes Opioid Use Disorder Introduction
        11.2.4 Alkermes Revenue in Opioid Use Disorder Business (2016-2021)
        11.2.5 Alkermes Recent Development
    11.3 Titan Pharmaceuticals
        11.3.1 Titan Pharmaceuticals Company Details
        11.3.2 Titan Pharmaceuticals Business Overview
        11.3.3 Titan Pharmaceuticals Opioid Use Disorder Introduction
        11.3.4 Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2016-2021)
        11.3.5 Titan Pharmaceuticals Recent Development
    11.4 Hikma Pharmaceuticals
        11.4.1 Hikma Pharmaceuticals Company Details
        11.4.2 Hikma Pharmaceuticals Business Overview
        11.4.3 Hikma Pharmaceuticals Opioid Use Disorder Introduction
        11.4.4 Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2016-2021)
        11.4.5 Hikma Pharmaceuticals Recent Development
    11.5 Teva Pharmaceuticals
        11.5.1 Teva Pharmaceuticals Company Details
        11.5.2 Teva Pharmaceuticals Business Overview
        11.5.3 Teva Pharmaceuticals Opioid Use Disorder Introduction
        11.5.4 Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2016-2021)
        11.5.5 Teva Pharmaceuticals Recent Development
    11.6 MediciNova
        11.6.1 MediciNova Company Details
        11.6.2 MediciNova Business Overview
        11.6.3 MediciNova Opioid Use Disorder Introduction
        11.6.4 MediciNova Revenue in Opioid Use Disorder Business (2016-2021)
        11.6.5 MediciNova Recent Development
    11.7 Orexo
        11.7.1 Orexo Company Details
        11.7.2 Orexo Business Overview
        11.7.3 Orexo Opioid Use Disorder Introduction
        11.7.4 Orexo Revenue in Opioid Use Disorder Business (2016-2021)
        11.7.5 Orexo Recent Development
    11.8 Camurus
        11.8.1 Camurus Company Details
        11.8.2 Camurus Business Overview
        11.8.3 Camurus Opioid Use Disorder Introduction
        11.8.4 Camurus Revenue in Opioid Use Disorder Business (2016-2021)
        11.8.5 Camurus Recent Development
    11.9 Omeros
        11.9.1 Omeros Company Details
        11.9.2 Omeros Business Overview
        11.9.3 Omeros Opioid Use Disorder Introduction
        11.9.4 Omeros Revenue in Opioid Use Disorder Business (2016-2021)
        11.9.5 Omeros Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Opioid Use Disorder Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Buprenorphine
    Table 3. Key Players of Methadone
    Table 4. Key Players of Naltrexone
    Table 5. Global Opioid Use Disorder Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Opioid Use Disorder Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Opioid Use Disorder Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Opioid Use Disorder Market Share by Regions (2016-2021)
    Table 9. Global Opioid Use Disorder Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Opioid Use Disorder Market Share by Regions (2022-2027)
    Table 11. Opioid Use Disorder Market Trends
    Table 12. Opioid Use Disorder Market Drivers
    Table 13. Opioid Use Disorder Market Challenges
    Table 14. Opioid Use Disorder Market Restraints
    Table 15. Global Opioid Use Disorder Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Opioid Use Disorder Market Share by Players (2016-2021)
    Table 17. Global Top Opioid Use Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Use Disorder as of 2020)
    Table 18. Ranking of Global Top Opioid Use Disorder Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Opioid Use Disorder Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Opioid Use Disorder Product Solution and Service
    Table 22. Date of Enter into Opioid Use Disorder Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Opioid Use Disorder Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Opioid Use Disorder Revenue Market Share by Type (2016-2021)
    Table 26. Global Opioid Use Disorder Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Opioid Use Disorder Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Opioid Use Disorder Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Opioid Use Disorder Revenue Market Share by Application (2016-2021)
    Table 30. Global Opioid Use Disorder Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Opioid Use Disorder Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Opioid Use Disorder Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Opioid Use Disorder Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Opioid Use Disorder Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Opioid Use Disorder Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Opioid Use Disorder Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Opioid Use Disorder Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Opioid Use Disorder Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Opioid Use Disorder Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Opioid Use Disorder Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Opioid Use Disorder Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Opioid Use Disorder Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Opioid Use Disorder Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Opioid Use Disorder Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Opioid Use Disorder Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Opioid Use Disorder Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Opioid Use Disorder Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Opioid Use Disorder Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Opioid Use Disorder Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Opioid Use Disorder Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Opioid Use Disorder Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Opioid Use Disorder Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Opioid Use Disorder Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Opioid Use Disorder Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Opioid Use Disorder Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Opioid Use Disorder Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Opioid Use Disorder Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Opioid Use Disorder Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Opioid Use Disorder Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Opioid Use Disorder Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Opioid Use Disorder Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Indivior Company Details
    Table 63. Indivior Business Overview
    Table 64. Indivior Opioid Use Disorder Product
    Table 65. Indivior Revenue in Opioid Use Disorder Business (2016-2021) & (US$ Million)
    Table 66. Indivior Recent Development
    Table 67. Alkermes Company Details
    Table 68. Alkermes Business Overview
    Table 69. Alkermes Opioid Use Disorder Product
    Table 70. Alkermes Revenue in Opioid Use Disorder Business (2016-2021) & (US$ Million)
    Table 71. Alkermes Recent Development
    Table 72. Titan Pharmaceuticals Company Details
    Table 73. Titan Pharmaceuticals Business Overview
    Table 74. Titan Pharmaceuticals Opioid Use Disorder Product
    Table 75. Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2016-2021) & (US$ Million)
    Table 76. Titan Pharmaceuticals Recent Development
    Table 77. Hikma Pharmaceuticals Company Details
    Table 78. Hikma Pharmaceuticals Business Overview
    Table 79. Hikma Pharmaceuticals Opioid Use Disorder Product
    Table 80. Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2016-2021) & (US$ Million)
    Table 81. Hikma Pharmaceuticals Recent Development
    Table 82. Teva Pharmaceuticals Company Details
    Table 83. Teva Pharmaceuticals Business Overview
    Table 84. Teva Pharmaceuticals Opioid Use Disorder Product
    Table 85. Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2016-2021) & (US$ Million)
    Table 86. Teva Pharmaceuticals Recent Development
    Table 87. MediciNova Company Details
    Table 88. MediciNova Business Overview
    Table 89. MediciNova Opioid Use Disorder Product
    Table 90. MediciNova Revenue in Opioid Use Disorder Business (2016-2021) & (US$ Million)
    Table 91. MediciNova Recent Development
    Table 92. Orexo Company Details
    Table 93. Orexo Business Overview
    Table 94. Orexo Opioid Use Disorder Product
    Table 95. Orexo Revenue in Opioid Use Disorder Business (2016-2021) & (US$ Million)
    Table 96. Orexo Recent Development
    Table 97. Camurus Company Details
    Table 98. Camurus Business Overview
    Table 99. Camurus Revenue in Opioid Use Disorder Business (2016-2021) & (US$ Million)
    Table 100. Camurus Recent Development
    Table 101. Omeros Company Details
    Table 102. Omeros Business Overview
    Table 103. Omeros Opioid Use Disorder Product
    Table 104. Omeros Revenue in Opioid Use Disorder Business (2016-2021) & (US$ Million)
    Table 105. Omeros Recent Development
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Opioid Use Disorder Market Share by Type: 2020 VS 2027
    Figure 2. Buprenorphine Features
    Figure 3. Methadone Features
    Figure 4. Naltrexone Features
    Figure 5. Global Opioid Use Disorder Market Share by Application: 2020 VS 2027
    Figure 6. Moderate Pain Treatment Case Studies
    Figure 7. Severe Pain Treatment Case Studies
    Figure 8. Opioid Use Disorder Report Years Considered
    Figure 9. Global Opioid Use Disorder Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Opioid Use Disorder Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Opioid Use Disorder Market Share by Regions: 2020 VS 2027
    Figure 12. Global Opioid Use Disorder Market Share by Regions (2022-2027)
    Figure 13. Global Opioid Use Disorder Market Share by Players in 2020
    Figure 14. Global Top Opioid Use Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Use Disorder as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Opioid Use Disorder Revenue in 2020
    Figure 16. Global Opioid Use Disorder Revenue Market Share by Type (2016-2021)
    Figure 17. Global Opioid Use Disorder Revenue Market Share by Type (2022-2027)
    Figure 18. North America Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Opioid Use Disorder Market Share by Type (2016-2027)
    Figure 20. North America Opioid Use Disorder Market Share by Application (2016-2027)
    Figure 21. North America Opioid Use Disorder Market Share by Country (2016-2027)
    Figure 22. United States Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Opioid Use Disorder Market Share by Type (2016-2027)
    Figure 26. Europe Opioid Use Disorder Market Share by Application (2016-2027)
    Figure 27. Europe Opioid Use Disorder Market Share by Country (2016-2027)
    Figure 28. Germany Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Opioid Use Disorder Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Opioid Use Disorder Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Opioid Use Disorder Market Share by Region (2016-2027)
    Figure 38. China Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Opioid Use Disorder Market Share by Type (2016-2027)
    Figure 46. Latin America Opioid Use Disorder Market Share by Application (2016-2027)
    Figure 47. Latin America Opioid Use Disorder Market Share by Country (2016-2027)
    Figure 48. Mexico Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Opioid Use Disorder Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Opioid Use Disorder Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Opioid Use Disorder Market Share by Country (2016-2027)
    Figure 54. Turkey Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Opioid Use Disorder Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Indivior Revenue Growth Rate in Opioid Use Disorder Business (2016-2021)
    Figure 58. Alkermes Revenue Growth Rate in Opioid Use Disorder Business (2016-2021)
    Figure 59. Titan Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2016-2021)
    Figure 60. Hikma Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2016-2021)
    Figure 61. Teva Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2016-2021)
    Figure 62. MediciNova Revenue Growth Rate in Opioid Use Disorder Business (2016-2021)
    Figure 63. Orexo Revenue Growth Rate in Opioid Use Disorder Business (2016-2021)
    Figure 64. Camurus Revenue Growth Rate in Opioid Use Disorder Business (2016-2021)
    Figure 65. Omeros Revenue Growth Rate in Opioid Use Disorder Business (2016-2021)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Indivior
Alkermes
Titan Pharmaceuticals
Hikma Pharmaceuticals
Teva Pharmaceuticals
MediciNova
Orexo
Camurus
Omeros
Frequently Asked Questions
Opioid Use Disorder report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Opioid Use Disorder report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Opioid Use Disorder report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Smart LED Lighting

Smart lighting is a lighting technology designed for energy efficiency. This may include high eff ... Read More

Athleisure

Athleisure is a trend in fashion in which clothing designed for workouts and other athletic activ ... Read More